TickerLeague

Stock-Based Compensation for IDEXX Laboratories (IDXX)

Stock-Based Compensation for IDEXX Laboratories (IDXX): headline value $88.17M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$88.17M

YoY change

-100.0%

5Y CAGR

-100.0%

Peak year (2024)

$60.30M

Latest annual

$0

Stock-Based Compensation history chart for IDEXX Laboratories (IDXX) from 1991 to 2025

Stock-Based Compensation history table for IDEXX Laboratories (IDXX) from 1991 to 2025

Fiscal yearPeriod endedReportedStock-Based CompensationYoY
2025$0-100.0%
2024$60.30M+0.9%
2023$59.74M+20.0%
2022$49.77M+31.8%
2021$37.76M+22.0%
2020$30.95M-21.2%
2019$39.28M+56.1%
2018$25.16M+7.0%
2017$23.52M+18.2%
2016$19.89M+0.0%
2015$19.88M+9.9%
2014$18.10M+9.4%
2013$16.54M+3.7%
2012$15.95M+2.9%
2011$15.50M+16.8%
2010$13.26M+14.1%
2009$11.62M+10.7%
2008$10.50M+19.7%
2007$8.78M-19.1%
2006$10.84M+7931.1%
2005$135,0000.0%
2004$135,000-2.2%
2003$138,000
2002$0
2001$0
2000$0
1999$0
1998$0
1997$0
1996$0
1995$0
1994$0
1993$0
1992$0
1991$0

Stock-Based Compensation values are taken from IDEXX Laboratories's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, IDEXX Laboratories (IDXX) reported stock-based compensation of $0 – plunged 100.0% year-over-year.

Looking at the 2020–2025 (5 years) stretch, IDEXX Laboratories stock-based compensation compounded at -100.0% per year, with a net decline across the window.

The dataset's maximum stock-based compensation sits at $60.30M (2024); the minimum reading of $0 dates to 1991.

Among 8 Healthcare peers, IDEXX Laboratories (IDXX) ranks 5th; the peer median for stock-based compensation is $313.00M.

IDEXX Laboratories Stock-Based Compensation by Year

IDEXX Laboratories Stock-Based Compensation 2025: $0

IDEXX Laboratories stock-based compensation in 2025 was $0, plunged 100.0% below 2024.

IDEXX Laboratories Stock-Based Compensation 2024: $60.30M

IDEXX Laboratories stock-based compensation in 2024 was $60.30M, edged up 0.9% from 2023. This figure represents the highest annual value in the available history.

IDEXX Laboratories Stock-Based Compensation 2023: $59.74M

IDEXX Laboratories stock-based compensation in 2023 was $59.74M, grew 20.0% from 2022.

IDEXX Laboratories Stock-Based Compensation 2022: $49.77M

IDEXX Laboratories stock-based compensation in 2022 was $49.77M, surged 31.8% from 2021.

IDEXX Laboratories Stock-Based Compensation 2021: $37.76M

IDEXX Laboratories stock-based compensation in 2021 was $37.76M.

See more financial history for IDEXX Laboratories (IDXX).

Sector peers — Stock-Based Compensation

Companies in the same sector as IDEXX Laboratories, ranked by their latest stock-based compensation.

CompanyStock-Based CompensationSector
Johnson & Johnson (JNJ)$1.35BHealthcare
UnitedHealth Group Incorporated (UNH)$971.00MHealthcare
AbbVie Inc. (ABBV)$955.00MHealthcare
Eli Lilly and Company (LLY)$626.00MHealthcare
AstraZeneca PLC (AZN)$0Healthcare
Merck & Co., Inc. (MRK)$0Healthcare
Amgen Inc. (AMGN)$0Healthcare
Novo Nordisk A/S (NVO)$0Healthcare

Frequently asked questions

What is IDEXX Laboratories's stock-based compensation?

Latest reported stock-based compensation for IDEXX Laboratories (IDXX) is $88.17M (period ending December 31, 2025).

How has IDEXX Laboratories stock-based compensation changed year-over-year?

IDEXX Laboratories (IDXX) stock-based compensation changed -100.0% year-over-year on the latest annual filing.

What is the long-term growth rate of IDEXX Laboratories stock-based compensation?

IDEXX Laboratories (IDXX) stock-based compensation compound annual growth rate is -100.0% over the most recent 5 years available.

When did IDEXX Laboratories stock-based compensation hit its highest annual value?

IDEXX Laboratories stock-based compensation reached its highest annual value of $60.30M in 2024.

What was IDEXX Laboratories stock-based compensation in 2024?

IDEXX Laboratories (IDXX) stock-based compensation in 2024 was $60.30M.

What was IDEXX Laboratories stock-based compensation in 2025?

IDEXX Laboratories (IDXX) stock-based compensation in 2025 was $0.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.